Yüklüyor......
Three months of rifapentine and isoniazid for latent tuberculosis infection in hemodialysis patients: High rates of adverse events
The consequences of once-weekly rifapentine plus isoniazid for 3 months (3HP) against latent tuberculosis infections in hemodialysis patients have not been studied before. This is the first study to evaluate the safety and tolerability of 3HP in this population and revealed a completion rate of 65.4...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2019-02-01
|
| Seri Bilgileri: | Journal of Microbiology, Immunology and Infection |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S1684118218301531 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|